Ann Arbor's Lycera In Collaboration With Pharma Giant MerckThe Ann Arbor pharma startup Lycera Corp. Tuesday announced a collaboration with pharma giant Merck to discover, developand commercialize small-molecule therapies directed at novel targets to treat a broad range of immune system disorders.

More From CBS Detroit

Daily J
Valenti and Foster

Watch & Listen